Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Filings indexed 680 across all filing types
Latest filing 2018-10-20 Regulatory Filings
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings
2018-10-20 English
Updates
Regulatory Filings
2018-10-17 English
Committee Meeting Updates
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges disclosing information about the capital restructuring of a non-material, unlisted subsidiary of the company. It details shareholding changes, issuance of fully convertible warrants, and post-conversion capital structure. The document is dated and signed by the Company Secretary & Compliance Officer. It is a regulatory disclosure related to shareholding and capital changes but does not contain comprehensive financial statements or detailed financial performance data. It is not an annual or interim report, earnings release, or audit report. The content fits best with a Capital/Financing Update as it informs about capital restructuring and issuance of warrants in a subsidiary. The document length (7438 characters) supports it being a substantive disclosure rather than a brief announcement. Therefore, the classification is Capital/Financing Update (CAP).
2018-09-22 English
Updates
Regulatory Filings
2018-09-19 English
Appointment
Regulatory Filings
2018-09-17 English
Outcome of Board Meeting
Regulatory Filings
2018-09-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.